Flucytosine - direct healthcare professional communication (DHPC)

About

This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.

Documents

Direct healthcare professional communication (DHPC): Flucytosine: Updated recommendations for the use in patients with dihydropyrimidine dehydrogenase (DPD) deficiency

Key facts

• Active substance:
  Flucytosine
• Procedure number:
  EMEA/H/A-31/1481
• Regulatory outcome:
  Variation
• DHPC type:
  Referral - Article 31
• Referral name:
  Fluorouracil and fluorouracil related substances (capecitabine, tegafur and flucytosine) containing medicinal products
• Human ATC codes:
  J02AX01
• Dissemination date:
  04/06/2020